When was BREFFI founded?

BREFFI was founded in 2012 and raised its 1st funding round 9 years after it was founded.

Where is BREFFI located?

BREFFI is headquartered in Moscow, Russia.

How many employees does BREFFI have?

As of Aug 31, 2026, the latest employee count at BREFFI is 46.

Is BREFFI a funded company?

BREFFI is a funded company, having raised a total of $***** in its 1st and only funding round, a Series B round on Dec 29, 2021.

When was the latest funding round of BREFFI?

BREFFI's latest funding was a $***** Series B round on Dec 29, 2021, with participation from 1 investor.

Where does BREFFI rank among its competitors?

BREFFI ranks 77th amongst 457 active competitors, of which 9 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Beesy Strategy, which secured an undisclosed amount in Feb, 2026.

Who are the top competitors of BREFFI?

BREFFI's top competitors include Zevra, Knight Therapeutics and Beesy Strategy. Among them, Beesy Strategy secured the most recent funding round in February, 2026.

BREFFI - 2026 Company Profile, Funding & Competitors

BREFFI is a series B company based in Moscow (Russia), founded in 2012. It operates as a Provider of market research services for biopharma industry. BREFFI has raised $10.2M in funding. The company has 457 active competitors, including 9 funded and 35 that have exited. Its top competitors include companies like Zevra, Knight Therapeutics and Beesy Strategy.

Key Metrics

Founded Year

2012

Location

Moscow, Russia

Stage

Series B

Total Funding

$10.2M in 1 round

Latest Funding Round

Series B, Dec 29, 2021, $*****

Investors

Elbrus Capital

Ranked

77^th among 457 active competitors

Employee Count

46 as on Aug 31, 2026

Similar Companies

Zevra & 462 more

View BREFFI's full profile

BREFFI has raised a total funding of $10.2M over 1 round. Its latest funding round was a Series B round on Dec 29, 2021 for $*****. 1 investor participated in its latest round. BREFFI has 1 institutional investor.

Here is the list of recent funding rounds of BREFFI:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 29, 2021	5676129	Series B	3407078	4378486	3343070	6050730

Access funding benchmarks and valuations. Sign up today!

View details of BREFFI's funding rounds and investors

BREFFI's employee count trend

BREFFI has 46 employees as of Aug 26. Here is BREFFI's employee count trend over the years:

Uncover BREFFI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BREFFI include Zevra, Knight Therapeutics and Beesy Strategy. Here is the list of Top 10 competitors of BREFFI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Zevra 2006, Celebration (United States), Public	Provider of marketing services for biopharma sector	-	TVM Capital	49/100
2nd	Knight Therapeutics 2014, Montreal (Canada), Public	Provider of marketing services for biopharma sector	-	-	43/100
3rd	Beesy Strategy New York City (United States), Series A	Provider of behavioral science research services for biopharmaceutical marketing strategy	$700K	Denali Growth	42/100
4th	CMI Media Group 1989, Cherry Hill (United States), Acquired	Full-service media agency focused on healthcare, wellness, and pharmaceutical marketing, offering people-based data and technology platform	-	-	42/100
5th	Inizio 2022, New York City (United States), Funding Raised	Provider of commercialization and clinical development solutions for life science companies	-	CD&R, National Science Foundation	42/100
6th	Life Science Connect 2009, Erie (United States), Late Stage	Provider of marketing and commercialization services for biopharma sector	-	Latticework Capital Management, Edgehill Management ... Read more	41/100
7th	SALUS 1969, Ljubljana (Slovenia), Unfunded	Provider of pharmaceutical products marketing services	-	-	38/100
8th	Ethosh 2012, Pune (India), Seed	Provider of digital experience and marketing services to health-tech and life-sciences organizations	$275K	-	38/100
9th	Weldon Biotech 2004, Delhi (India), Unfunded	Provider of sales and marketing services for diagnostics reagents and instruments	-	-	38/100
10th	Techizer 2011, Mumbai (India), Seed	Provider of marketing software for pharmacies	$84.8K	Smt Family Private Trust & 1 others	38/100
77th	BREFFI 2012, Moscow (Russia), Series B	Provider of market research services for biopharma industry	$10.2M	Elbrus Capital	22/100